Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-25-000382
Filing Date
2025-05-02
Accepted
2025-05-02 16:36:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2786
  Complete submission text file 0001972362-25-000382.txt   4337
Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Reporting) CIK: 0001679076 (see all company filings)

Type: 144

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38959 | Film No.: 25909269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)